BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 24, 1999

View Archived Issues

Bristol-Myers Squibb pioneers pharmacogenomic approach to cancer therapy, enters new alliance

Read More

Inosine dramatically stimulates axonal regeneration

Read More

Preliminary survival data from single Maxamine site submitted to ASCO

Read More

SuperGen and Stehlin Foundation extend research and licensing agreement

Read More

Combination A6 and tamoxifen effective in rat breast tumor

Read More

Financial results and R&D highlights at Texas Biotechnology

Read More

Protein Sciences and Pasteur Merieux Connaught expand influenza collaboration

Read More

New taxane analogue from Bristol-Myers Squibb now in phase I testing

Read More

Microcide's novel cephalosporin antibiotic enters the clinic

Read More

U.S. academic team takes a novel approach to treating prostate cancer

Read More

Following pre-NDA meeting, Genelabs to seek approval of GL-701 for treatment of SLE

Read More

Anticoagulant serine protease inhibitors described by 3-D

Read More

Novel Y5 receptor ligands in development at Ortho-McNeil for obesity and other disorders

Read More

Inhibitors of Na+/H+ exchange disclosed by Fujisawa

Read More

Agents for ulcers and other GI disorders under study at AstraZeneca

Read More

VEGF receptor tyrosine kinase inhibitor PTK-787 is a potent antiangiogenic agent

Read More

Merck's new PDE5 inhibitors useful for impotence, cardiovascular disorders

Read More

Topical antifungal agents with in vitro and in vivo efficacy developed at Hanwha

Read More

Multiple-dose PK and safety data reported at AAPS meeting for pregabalin

Read More

Bayer presents novel camptothecin glycoconjugates at AACR-NCI-EORTC meeting

Read More

Influence of cardiac output on clearance of dexmedetomidine

Read More

Darbufelone: bioavailability, multiple-dose PK, interactions with MTX discussed at AAPS

Read More

European screening program identifies novel anticancer drug candidate

Read More

Radicicol derivative KF-58333 is a promising antileukemia agent

Read More

More promising cancer news from AACR-NCI-EORTC: Hughes Institute presents new compounds

Read More

FDA approves Aggrenox for prevention of recurrent stroke

Read More

Timetable for Shire-Roberts merger

Read More

InKine seeks FDA approval of Diacol

Read More

Palatin Technologies submits BLA for LeuTech imaging agent

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 10, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing